Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors
Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors have?
Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors has 18 citations in the OpenAlex counts ScholarIQ stores.
When was Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors published?
Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors has 2018 year in the ScholarIQ index.
What is the open-access status of Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors?
Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors has closed oa status in the ScholarIQ index.
What is the DOI of Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors?
The DOI for Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors is on the source record.
What is the PMID of Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors?
The PMID for Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors is on the source record.
What is the OpenAlex record for Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors?
The OpenAlex for Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors is on the source record.